Anti-MCM5 antibody
5
(4 Reviews)
|
(29 Publications)
Rabbit Polyclonal MCM5 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 29 publications. Immunogen corresponding to Synthetic Peptide within Human MCM5.
View Alternative Names
CDC46, MCM5, DNA replication licensing factor MCM5, CDC46 homolog, P1-CDC46
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MCM5 antibody (AB17967)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human lung carcinoma (left) and mouse renal cell carcinoma (right) tissues labelling MCM5 with ab17967 at 1/1000 (1µg/ml). Detection : DAB.
- WB
Supplier Data
Western blot - Anti-MCM5 antibody (AB17967)
All lanes:
Western blot - Anti-MCM5 antibody (ab17967) at 0.05 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
Jurkat whole cell lysate at 50 µg
Predicted band size: 82 kDa
false
Exposure time: 10s
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
As a component of the MCM2-7 hexameric complex MCM5 contributes to the unwinding of DNA an essential step for replication. This complex acts as a helicase unwinding the DNA double helix at replication origins. This activity is required for laying down the replication fork and allowing access for the DNA polymerase. MCM5 integrates into the larger assembly of the replication machinery working in concert with cell cycle regulators to ensure proper cell cycle progression.
Pathways
MCM5 participates in DNA replication and cell cycle control pathways. It closely associates with the GINS complex and CDC45 forming the CMG (CDC45-MCM-GINS) complex which is critical for replication fork progression. MCM5 also interacts with the ATR-mediated DNA damage repair pathway. This relationship provides a checkpoint mechanism to halt replication in response to DNA damage allowing time for repair processes to maintain genomic stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (29)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 14:5147 PubMed37620345
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:105974 PubMed36756367
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6090 PubMed36241664
2022
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 7:102 PubMed35414135
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 15: PubMed35337060
2022
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 5: PubMed35091422
2022
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 4:767 PubMed34158617
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical epigenetics 13:37 PubMed33596994
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature 587:297-302 PubMed33087936
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:3951 PubMed32769987
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com